The Amgen Foundation is inviting applications for its Competitive Grant Program in Migraine Research.
Through the program, grants of between $50,000 and $150,000 will be awarded to early-career investigators in support of novel research proposals that seek to advance the medical knowledge of migraine. Eligible research includes non-interventional clinical research, with a focus on early diagnosis and treatment, epidemiology, and Patient Reported Outcomes (PRO)/Quality of Life (QoL) measures; biomarkers for diagnosis and prognosis; and preclinical research focused on mechanism of disease (non-calcitonin gene-related peptide [CGRP]- and non-pituitary adenylate cyclase-activating polypeptide [PACAP]-related).
To be eligible, applicants must be an early-career investigator (interns, residents, headache medicine fellows, and healthcare professionals within five years of completion of training) based in the United States.
See the Amgen Foundation website for complete program guidelines and application instructions.